CYTK

CYTOKINETICS INC

CYTK·23282W605·US·Common Stock·Healthcare - Biotechnology-13D/G

CYTK (CYTOKINETICS INC) is held by 196 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($1.1B), FMR LLC ($706.8M), WELLINGTON MANAGEMENT GROUP LLP ($527.9M). Net institutional sentiment: Mixed. In Q1 2026, 2 members of Congress and 117 funds bought CYTK.

196
Holders
(19 Elite)
$7.1B
Total Value
57% (204)
Consensus
117 buying - 87 selling
13F: Insider & Congress:
CYTK

Smart Money Verdict

View all
Held by 196 funds
19 elite

Who's Trading

InsiderMIMalik Fady IbrahamSell $282KJul 21, 2026
InsiderBIBlum Robert ISell $614KJul 13, 2026
InsiderBIBlum Robert ISell $820.2Jul 13, 2026
ActivistFMR LLCFMR LLC3.9%Jul 8, 2026
CongressGilbert CisnerosGilbert CisnerosBuy $1,001 - $15,000Jun 30, 2026
InsiderBIBlum Robert ISell $584KMay 14, 2026
ActivistFMR LLCFMR LLC9.0%May 6, 2026
CongressGilbert CisnerosGilbert CisnerosBuy $1,001 - $15,000Oct 9, 2025
CongressLisa McClainLisa McClainSale $1,001 - $15,000Jun 17, 2025
CongressLisa McClainLisa McClainBuy $1,001 - $15,000Jun 11, 2025

Top Holders

Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
16.5M(+0.9%)$1.1B0.0%+60.24%
32
Decreased
10.7M(-16.3%)$706.8M0.0%+63.07%
0
Increased
8M(+0.9%)$527.9M0.1%+55.37%
32
New
5.8M$385.2M0.0%+26.42%
43
Decreased
5.7M(-1.4%)$378.7M0.0%+6.39%
0
New
5.5M$361.8M0.0%+26.42%
43
New
3.3M$219.7M2.2%+26.42%
80
Increased
3.2M(+5.2%)$212M0.0%+115.80%
32
Increased
3.1M(+6.3%)$206M0.0%+67.40%
33
Unchanged
2.7M$179.4M1.8%+160.58%
0
Decreased
2.2M(-7.0%)$145.4M0.0%+46.63%
0
Increased
2.1M(+83.6%)$136.9M0.0%+51.29%
47
Decreased
1.7M(-31.4%)$109.5M0.4%+94.66%
0
Decreased
1.6M(-17.9%)$104.4M0.0%+20.03%
0
Increased
1.5M(+18.9%)$99.2M0.0%+43.20%
35
Increased
1.4M(+4.4%)$95M0.0%+162.43%
31
Increased
1.4M(+1.0%)$92.1M0.0%+108.05%
30
Increased
1.3M(+13.6%)$88.2M0.0%+57.90%
34
Decreased
1.1M(-5.4%)$72.5M0.0%+56.40%
0
Increased
1.1M(+11.9%)$72.1M0.0%+102.15%
33

Showing 1-20 of 216

1 / 11
CYTKCYTKCYTOKINETICS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used